You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Val Müstair Graubünden

Showing 1 - 25 of 56
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Seroprevalence of Leptospirosis in Val Müstair, Switzerland

Recruiting
  • Leptospirosis
  • +2 more
  • Blood sample collection
  • Data collection
  • Basel, Switzerland
  • +1 more
Mar 18, 2022

Melanoma and Metastatic Colorectal Cancer Trial in Worldwide (LGX818)

Active, not recruiting
  • Melanoma and Metastatic Colorectal Cancer
  • Toulouse, Haute-garonne, France
  • +7 more
Dec 2, 2021

Formulary Coverage of Entresto on Prescription

Completed
  • Chronic Heart Failure
    • Durham, North Carolina
      IQVIA
    Apr 27, 2023

    Solid Tumors, Neuroblastoma, Rhabdomyosarcoma Trial in Durham, Cincinnati (VAL-413, Temozolomide)

    Recruiting
    • Solid Tumors
    • +5 more
    • Durham, North Carolina
    • +2 more
    Jan 31, 2023

    Lung Diseases, Surgery Trial in Jinan (robotic surgery, uniport surgery, multiple- port surgery)

    Recruiting
    • Lung Diseases
    • Surgery
    • robotic surgery
    • +2 more
    • Jinan, Shandong, China
      The Second Hospital of Shandong University
    Feb 27, 2022

    Lafora Disease Trial (VAL-1221)

    Available
    • Lafora Disease
    • (no location specified)
    Jun 25, 2023

    Gastrointestinal Dysfunction Trial in Nottingham (Oral glucose tolerance test)

    Recruiting
    • Gastrointestinal Dysfunction
    • Oral glucose tolerance test
    • Nottingham, Notts, United Kingdom
      Sir Peter Mansfield Imaging Centre
    Feb 28, 2023

    Herpes Simplex 2, Meningitis, Viral Trial (Acyclovir 50 MG/ML, Placebo)

    Not yet recruiting
    • Herpes Simplex 2
    • Meningitis, Viral
    • Acyclovir 50 MG/ML
    • Placebo
    • (no location specified)
    Jul 11, 2022

    Sacubitril/Valsartan Treated Adult Chronic Heart Failure

    Completed
    • Chronic Heart Failure
    • East Hanover, New Jersey
      Novartis Investigative Site
    Nov 11, 2022

    Axial Spondyloarthritis Questionnaires (Val-SpA)

    Completed
    • Axial Spondyloarthritis
    • Ankylosing Spondylitis
      • Grenoble Cedex 9, France
      • +1 more
      Nov 18, 2022

      Recurrent Ovarian Carcinoma Trial in Worldwide (Bevacizumab, Atezolizumab, Chemotherapy)

      Active, not recruiting
      • Recurrent Ovarian Carcinoma
      • Innsbruck, Austria
      • +110 more
      Jul 25, 2022

      Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

      Active, not recruiting
      • Glioma
      • +4 more
      • VAL-083, Dianhydrogalactitol
      • Houston, Texas
        University of Texas MD Anderson Cancer Center
      Mar 23, 2022

      Acute Myocardial Infarction Trial in Alexandria (Sacubitril / Valsartan Oral Tablet [Entresto])

      Recruiting
      • Acute Myocardial Infarction
      • Sacubitril / Valsartan Oral Tablet [Entresto]
      • Alexandria, Egypt
        Andalusia Hospitals
      May 28, 2021

      Cancer Trial (VAL-083)

      Available
      • Cancer
      • (no location specified)
      Nov 14, 2021

      Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

      Active, not recruiting
      • Glioma
      • +4 more
      • VAL-083 (Dianhydrogalactitol)
      • Guangzhou, China
        Sun Yat-Sen University Cancer Center
      Mar 23, 2022

      National Observatory of Interventional Cardiology

      Recruiting
      • Interventional
      • +5 more
        • Le Coudray, Eure Et Loire, France
        • +14 more
        Mar 29, 2022

        Heart Failure With Reduced Ejection Fraction Patients Treated

        Completed
        • Heart Failure
        • Trieste, Italy
          Novartis Investigative Site
        Nov 7, 2022

        Colorectal Cancer Trial in Tours (CRC screening invitation not including the screening test., Mailing of FIT with invitation,

        Not yet recruiting
        • Colorectal Cancer
        • CRC screening invitation not including the screening test.
        • +2 more
        • Tours, France
          Crcdc-Cvl
        Sep 4, 2023

        Cardiac Valve Disease, Coronary Artery Disease, Organ Failure, Multiple Trial in Leicester (Sodium Valproate)

        Recruiting
        • Cardiac Valve Disease
        • +2 more
        • Sodium Valproate
        • Leicester, Leicestershire, United Kingdom
          Glenfield Hospital
        Apr 29, 2021

        Gastric Cancer Trial in Seoul (Antiviral treatment in combination with low-dose gemcitabine)

        Not yet recruiting
        • Gastric Cancer
        • Antiviral treatment in combination with low-dose gemcitabine
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Jun 21, 2022

        Influenza Trial in Miami (VAL-339851, Placebo)

        Completed
        • Influenza
        • VAL-339851
        • Placebo
        • Miami, Florida
          Miami Research Associates
        Jan 7, 2021

        HER2-negative Breast Cancer, Triple Negative Breast Cancer Trial in France, Germany, Ireland (Capecitabine, Carboplatin,

        Recruiting
        • HER2-negative Breast Cancer
        • Triple Negative Breast Cancer
        • Brasschaat, Belgium
        • +161 more
        Nov 2, 2022

        Brain Derived Neurotrophic Factor rs6265 Gene Polymorphism With

        Not yet recruiting
        • Epilepsy
        • Genotyping by Real Time PCR
        • (no location specified)
        Oct 14, 2021

        Prostate Cancer Trial in New York (68Ga-RM2 (RM2), PET/CT Scan)

        Completed
        Has Results
        • Prostate Cancer
        • 68Ga-RM2 (RM2)
        • PET/CT Scan
        • New York, New York
          Memorial Sloan Kettering Cancer Center
        Apr 27, 2021

        Diabetes, Type 2, Cognitive Dysfunction, Epigenetics, Exercise Trial (Aerobic exercise program, Stretching exercise)

        Unknown status
        • Diabetes Mellitus, Type 2, Cognitive Dysfunction, Epigenetics, Exercise
        • Aerobic exercise program
        • Stretching exercise
        • (no location specified)
        Oct 26, 2020